CCL2 and breast carcinoma: Our previous work with breast cancer patients demonstrated that high levels of TGF-β, TNF-α, VEGF, IL-6, IL-8, and IL-10 correlated with poor prognosis, while IL-21 and CCL-2 are related to a better outcome.